Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, H…

Drug Manufacturers - General

US, Indianapolis [HQ]

News

Theses · Events · Sentiments

Events

There will be an upcoming dividend payment of $

Sentiments

24-11-20 35.00%

— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics' AI-Enabled, All-in-Human CONVERGE® Platform

24-11-13 52.80%

If Wall Street's right, investors will get a lot more than just rising dividend payments from this pair.

24-11-08 0.00%

The market's perception of the pharmaceutical company has undeniably shifted.

24-11-01 -33.40%

The market overreacted to Lilly's Q3 earnings miss and full-year guidance cut.

24-10-30 25.00%

Revenue in Q3 2024 increased 20%, driven by volume growth from Mounjaro and Zepbound, partially offset by $1.42 billion of …

24-10-29 -50.00%

The odds of its new drug getting established in the U.K. are now much lower.

24-10-16 51.40%

These are two of healthcare's biggest darlings right now, but one looks better positioned for the long run.